Literature DB >> 23960946

A review of canaloplasty.

Ben J Harvey1, Mahmoud A Khaimi.   

Abstract

Canaloplasty is a method of lowering intraocular pressure (IOP) by which a flexible, beacon-tipped microcatheter equipped with an ophthalmic viscosurgical device (OVD) delivery system is used to catheterize and introduce a suture into Schlemm's canal. Ligation of this suture provides tension on the canal and facilitates aqueous outflow. Canaloplasty is designed to be a blebless procedure that requires no antifibrotic agents and has been shown to safely and effectively lower IOP in patients with open-angle glaucoma (OAG) with minimal complications. Most importantly, no bleb-related adverse events are associated with this procedure. When contemplating surgical management of OAG, canaloplasty may be considered.

Entities:  

Keywords:  Canaloplasty; Phacoemulsification; Schlemm’s canal; Trabeculectomy

Year:  2011        PMID: 23960946      PMCID: PMC3729506          DOI: 10.1016/j.sjopt.2011.08.003

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  31 in total

1.  Canaloplasty in one eye compared with viscocanalostomy in the contralateral eye in patients with bilateral open-angle glaucoma.

Authors:  Norbert Josef Koerber
Journal:  J Glaucoma       Date:  2012-02       Impact factor: 2.503

2.  Circumferential viscocanalostomy and suture canal distension (canaloplasty) for whites with open-angle glaucoma.

Authors:  Matthias C Grieshaber; Stephan Fraenkl; Andreas Schoetzau; Josef Flammer; Selim Orgül
Journal:  J Glaucoma       Date:  2011 Jun-Jul       Impact factor: 2.503

3.  Endophthalmitis after filtering surgery with mitomycin.

Authors:  D S Greenfield; I J Suñer; M P Miller; T A Kangas; P F Palmberg; H W Flynn
Journal:  Arch Ophthalmol       Date:  1996-08

4.  Canaloplasty: Three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucoma.

Authors:  Richard A Lewis; Kurt von Wolff; Manfred Tetz; Norbert Koerber; John R Kearney; Bradford J Shingleton; Thomas W Samuelson
Journal:  J Cataract Refract Surg       Date:  2011-04       Impact factor: 3.351

5.  Racial differences in the results of glaucoma filtration surgery: are racial differences in the conjunctival cell profile important?

Authors:  D Broadway; I Grierson; R Hitchings
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

6.  The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-12

7.  Three and five year changes in intraocular pressures after clear corneal phacoemulsification in open angle glaucoma patients, glaucoma suspects, and normal patients.

Authors:  Bradford J Shingleton; James J Pasternack; James W Hung; Mark W O'Donoghue
Journal:  J Glaucoma       Date:  2006-12       Impact factor: 2.503

8.  Clinical evaluation of the aqueous outflow system in primary open-angle glaucoma for canaloplasty.

Authors:  Matthias C Grieshaber; Ané Pienaar; Jan Olivier; Robert Stegmann
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

9.  Circumferential viscodilation and tensioning of Schlemm canal (canaloplasty) with temporal clear corneal phacoemulsification cataract surgery for open-angle glaucoma and visually significant cataract: one-year results.

Authors:  Bradford Shingleton; Manfred Tetz; Norbert Korber
Journal:  J Cataract Refract Surg       Date:  2008-03       Impact factor: 3.351

Review 10.  Dysfunctional filtering blebs.

Authors:  A Azuara-Blanco; L J Katz
Journal:  Surv Ophthalmol       Date:  1998 Sep-Oct       Impact factor: 6.048

View more
  11 in total

1.  Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty-1-year results.

Authors:  Anna-Maria Seuthe; Ciprian Ivanescu; Stephan Leers; Karl Boden; Kai Januschowski; Peter Szurman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-05-10       Impact factor: 3.117

2.  Ab interno canaloplasty (ABiC)-12-month results of a new minimally invasive glaucoma surgery (MIGS).

Authors:  Anja-Maria Davids; Milena Pahlitzsch; Alexander Boeker; Sibylle Winterhalter; Anna-Karina Maier-Wenzel; Matthias Klamann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-06-08       Impact factor: 3.117

3.  Comparison of canaloplasty and trabeculectomy for open angle glaucoma: a Meta-analysis.

Authors:  Zhong-Jing Lin; Shuo Xu; Shou-Yue Huang; Xiao-Bin Zhang; Yi-Sheng Zhong
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

4.  Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids.

Authors:  Thania Bogarin; Sindhu Saraswathy; Goichi Akiyama; Xiaobin Xie; Robert N Weinreb; Jie Zheng; Alex S Huang
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

Review 5.  Progression on canaloplasty for primary open angle glaucoma.

Authors:  Jun Zhang; Ning-Li Wang
Journal:  Int J Ophthalmol       Date:  2019-10-18       Impact factor: 1.779

6.  Can perforations of descemet's window (DW) improve the outcome of canaloplasty in open angle glaucoma?

Authors:  Barbara Pullig; Norbert Josef Koerber; Thomas Dietlein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-05-06       Impact factor: 3.117

7.  Canaloplasty versus Viscocanalostomy in Primary Open Angle Glaucoma.

Authors:  Faried Mohammed Wagdy
Journal:  Electron Physician       Date:  2017-01-25

Review 8.  Improvement of the Safety Profile of Canaloplasty and Phacocanaloplasty: A Review of Complications and Their Management.

Authors:  Joanna Konopińska; Zofia Mariak; Marek Rękas
Journal:  J Ophthalmol       Date:  2020-06-16       Impact factor: 1.909

Review 9.  Canaloplasty in the Treatment of Primary Open-Angle Glaucoma: Patient Selection and Perspectives.

Authors:  Anna Byszewska; Joanna Konopińska; Aleksandra Kinga Kicińska; Zofia Mariak; Marek Rękas
Journal:  Clin Ophthalmol       Date:  2019-12-31

Review 10.  Canaloplasty: A Minimally Invasive and Maximally Effective Glaucoma Treatment.

Authors:  Mahmoud A Khaimi
Journal:  J Ophthalmol       Date:  2015-10-01       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.